About the Novel Agent Pilot Award
The Novel Agent Pilot Awards supports collaborations between basic scientists and physician-scientists with the goal of developing biological agents to treat cancer. Projects should focus on the discovery of anti-cancer molecules (drugs and biologics) by Massey investigators and evaluation of molecules in the laboratory and ultimately, patients. These pilots may include research focused on small molecule drugs, antibodies, vaccines, CAR-T and other cell therapies that selectively kill tumors but not normal cells.
Award details and eligibility criteria
- Award amounts are tailored to the scope and maturity of the drug development project.
- Applications should be a multi-principal investigator (MPI) among basic and translational researchers. Each PI must be a full-time VCU faculty member, and at least one of the PIs must be a Massey research member.
- IND-guided advanced preclinical studies are not supported through this award mechanism and should not be included in the proposal.
- A Massey investigator may only hold one active pilot research award at a time
Questions?
Contact Alex Haynes at haynesa4@vcu.edu.